Cytomegalovirus (CMV) Infection in Amniotic Fluid
NCT00194142 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37
Last updated 2016-08-17
Summary
The purpose of this study is to determine if detection of cytomegalovirus (CMV) in amniotic fluid collected in the second trimester of pregnancy is associated with pregnancy complications such as preterm delivery or severe preeclampsia.
Conditions
- Pregnancy Complications
- Cytomegalovirus Infections
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Doris Chou, MD · University of Pennsylvania
Eligibility
- Min Age
- 15 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-07-31
- Primary Completion
- 2008-05-31
- Completion
- 2008-05-31
Countries
- United States
Study Locations
More Related Trials
-
Prenatal Behavioral Intervention to Prevent Maternal Cytomegalovirus (CMV) in Pregnancy
NCT04615715 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of Congenital Cytomegalovirus Infection in Newborn With Particular Risk
NCT05754879 ·Status: COMPLETED
-
A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China
NCT02645396 ·Status: COMPLETED
-
Assessment of Post-traumatic Stress Disorder (PTSD) in Patients Monitored for Cytomegalovirus (CMV) Seroconversion During Pregnancy,
NCT04658810 ·Status: COMPLETED
-
Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)
NCT05170269 ·Status: TERMINATED ·Phase: PHASE3
-
A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China
NCT02710864 ·Status: COMPLETED
-
Transfusion-Transmitted Cytomegalovirus Prevention in Neonates
NCT00000584 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Outcomes of Children With Congenital CMV in New York State
NCT06226558 ·Status: RECRUITING
-
Screening for Congenital Cytomegalovirus Infection in Newborns
NCT02683096 ·Status: COMPLETED
-
Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection
NCT01659684 ·Status: UNKNOWN ·Phase: NA
-
Comparing Infectious Morbidity Among Women With Meconium-stained Amniotic Fluid at Term, Between Those Treated With Prophylactic Antibiotics Zinacef vs. Placebo
NCT06849037 ·Status: RECRUITING ·Phase: NA
-
Does Normal Brain Imaging Predict Normal Neurodevelopmental Outcome in Fetuses With Proven Cytomegalovirus Infection?
NCT00872703 ·Status: COMPLETED
-
Detection of Human Cytomegalovirus in the Saliva
NCT00815802 ·Status: COMPLETED
-
Epidemiology and Prevention of Congenital HCMV in Immune Mothers. Congenital HCMV Infection Lombardy
NCT03973359 ·Status: UNKNOWN ·Phase: NA
-
Epidemiology of Human Cytomegalovirus Excretion in the Saliva of Children Attending Nursery in France
NCT01704222 ·Status: COMPLETED
-
Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients
NCT00699868 ·Status: COMPLETED ·Phase: NA
-
Inflammation and Treatment of Bacterial Vaginosis Near Term
NCT00720291 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening
NCT02139423 ·Status: COMPLETED ·Phase: NA
-
Diaplacental Transfer of Anti-HCMV- and Anti-VZV-immunoglobulin G (IgG) -Antibodies at Premature and Mature Newborns
NCT02689700 ·Status: UNKNOWN
-
COVID-19 and Obstetric Transmission
NCT04418557 ·Status: COMPLETED
-
Clinical Trial of Behavioral Modification to Prevent Congenital Cytomegalovirus
NCT01819519 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection
NCT00881517 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Biochip for HCMV Detection in Breast Milk
NCT02840825 ·Status: TERMINATED
-
Non Primary HCMV Infection: Natural History and Immune Response
NCT06337955 ·Status: ACTIVE_NOT_RECRUITING
-
In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life
NCT04921241 ·Status: COMPLETED